CG
TMO icon

CFO4Life Group’s Thermo Fisher Scientific TMO Stock Holding History

CFO4Life Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-447
Closed -$259K – 244
2025
Q4 		$259K Sell
447
-3
-0.7% -$1.7K 0.04% 198
2025
Q3 		$218K Buy
+450
New +$209K 0.03% 213
2025
Q2 		– Sell
-429
Closed -$213K – 244
2025
Q1 		$213K Sell
429
-2
-0.5% -$1.08K 0.04% 198
2024
Q4 		$224K Buy
431
+17
+4% +$9.35K 0.04% 190
2024
Q3 		$256K Sell
414
-2
-0.5% -$1.18K 0.05% 173
2024
Q2 		$230K Buy
416
+14
+3% +$8.02K 0.04% 174
2024
Q1 		$234K Buy
+402
New +$226K 0.04% 166
2023
Q3 		– Sell
-1,582
Closed -$825K – 182
2023
Q2 		$825K Sell
1,582
-40
-2% -$21.6K 0.18% 64
2023
Q1 		$935K Buy
1,622
+54
+3% +$30.4K 0.21% 52
2022
Q4 		$864K Sell
1,568
-212
-12% -$112K 0.18% 66
2022
Q3 		$903K Buy
1,780
+312
+21% +$175K 0.24% 48
2022
Q2 		$764K Sell
1,468
-71
-5% -$39.1K 0.19% 57
2022
Q1 		$909K Buy
1,539
+6
+0.4% +$3.45K 0.19% 55
2021
Q4 		$1.02M Buy
1,533
+108
+8% +$67.4K 0.21% 54
2021
Q3 		$814K Buy
1,425
+171
+14% +$93.9K 0.19% 61
2021
Q2 		$633K Buy
1,254
+32
+3% +$15.1K 0.15% 72
2021
Q1 		$558K Buy
1,222
+6
+0.5% +$2.86K 0.14% 79
2020
Q4 		$567K Buy
1,216
+22
+2% +$10.3K 0.16% 71
2020
Q3 		$527K Buy
1,194
+280
+31% +$116K 0.18% 62
2020
Q2 		$331K Sell
914
-663
-42% -$222K 0.13% 84
2020
Q1 		$447K Sell
1,577
-87
-5% -$27.4K 0.24% 57
2019
Q4 		$540K Sell
1,664
-41
-2% -$12.4K 0.23% 65
2019
Q3 		$497K Sell
1,705
-239
-12% -$68.4K 0.22% 67
2019
Q2 		$571K Buy
1,944
+2
+0.1% +$551 0.26% 61
2019
Q1 		$532K Buy
+1,942
New +$483K 0.25% 61

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CFO4Life Group's TMO Position: Q1 2026 in Review

CFO4Life Group sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 447 shares — an estimated $259K sold.

CFO4Life Group first reported a position in TMO in Q1 2019 and held it in 25 quarters. The position peaked at $1.02M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • CFO4Life Group reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • CFO4Life Group sold 447 Thermo Fisher Scientific shares in Q1 2026, an estimated $259K.
  • CFO4Life Group first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 25 quarters.
  • CFO4Life Group's Thermo Fisher Scientific position peaked at $1.02M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.